A multicenter Retrospective Study of Rapid Ramp-up of Bispecific Antibodies for Relapsed or Refractory Large B-cell Lymphoma Read more
A Multicenter Retrospective Study of the Safety and Efficacy of Nivolumab (Nivo) in Combination with Doxorubicin, Vinblastine, and Dacarbazine (AVD) for the Frontline Treatment of Advanced Stage Hodgkin Lymphoma (HL) – A Real-World Study Read more
Real world outcomes of patients with limited-stage diffuse large B-cell lymphoma treated with abbreviated R-CHOP immunochemotherapy Read more
Impact of Salvage Therapy on Outcomes in Patients with Relapsed/Refractory ALK+ Anaplastic Large Cell Lymphoma Prior to Autologous or Allogeneic Stem Cell Transplant Read more
Phase 1, Open-Label Study of Autologous SIRPA-low Macrophages (SIRPant-M) a cellular therapeutic product Administered by Intratumoral Injection Alone or in Combination with Focal External-Beam Radiotherapy in Participants with Relapsed or Refractory Non-Hodgkin’s Lymphoma Read more
TP53-Altered Aggressive Large B-Cell Lymphoma Outcomes by Treatment Modality: A Multicenter Retrospective Review Read more
Multisite, retrospective chart review of practice patterns and outcomes in patients with early-stage classical HL at different institutions within the United States Read more
Characterization and treatment of daratumumab-associated infections in patients with multiple myeloma. Read more
Impact of novel salvage regimens in patients with relapsed/refractory primary mediastinal B-cell lymphoma prior to autologous stem cell transplant Read more
